Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Tartrate for Intraoperative Floppy Iris Syndrome
NCT03760185Phase 2Completed
- Sponsor
- Denver Health
- Start
- Jan 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine in intraoperative floppy iris syndrome (IFIS), sponsored by Denver Health. Started Jan 2019; status: completed.
02
Drugs
brimonidine
03
Conditions
intraoperative floppy iris syndrome (IFIS)
Beyond the preview
Go deeper on NCT03760185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03760185.